AN2 Therapeutics, Inc.

ANTX • NASDAQ • Stock Fundamentals

AN2 Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Eric E. Easom, with a market cap of $160.3M.

Market Cap$160.3M

Employees36.0

CEOEric E. Easom

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 11, 2026 · 1 month 3 days agoQ1 2026

Next EarningsAug 11, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about AN2 Therapeutics, Inc.

AN2 Therapeutics, Inc. (ANTX) has a market capitalization of $160.3M and trades on NASDAQ.

AN2 Therapeutics, Inc. has approximately 36 employees.